Kuntal Ganguly | Lead Scientist - Formulation and Development
Venus Remedies Limited

Kuntal Ganguly, Lead Scientist - Formulation and Development, Venus Remedies Limited

Dr. Kuntal Ganguly serves as the Lead Scientist – Formulation & Development at Venus Medicine Research Center (VMRC), Venus Remedies Limited, India.
With more than 12 years of active research experience in Pharmaceutical and Biopharmaceutical formulation development, including therapeutic macromolecules, he is involved with designing primary and secondary screening cascades for drug discovery and follow lead drug candidates through to development.
He is actively working on Nano-/Micro-Delivery platforms for Antimicrobial Resistance, Cancer therapy, along with screening of novel Antimicrobial Resistance Breakers (ARBs).
Dr. Kuntal Ganguly is a member of American Association of Pharmaceutical Scientists (AAPS), Royal Society of Chemistry, UK.  Dr. Kuntal Ganguly is credited with 14 high-impact publications and multiple International Poster Presentations in the area of novel drug delivery mechanisms.


World Anti-Microbial Resistance Congress USA 2018 - Day 1 @ 12:35

Stealth targeted nanoparticles (STN): A platform to fast-track poorly bioavailable antibiotics into Oral dosage form

  • Conundrums of IV to Oral shift: Clinical implications
  • Our experiences from the STN Development Programme
  • Advancing IV breakthrough drugs to Oral therapy during drug development programs
  • Redefining the economics of antibiotic drug development
last published: 12/Oct/18 20:55 GMT

back to speakers